Ravi Salgia to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Ravi Salgia has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.976
-
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer. Chest. 2021 09; 160(3):1095-1107.
Score: 0.784
-
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report. Cold Spring Harb Mol Case Stud. 2020 12; 6(6).
Score: 0.192